Theragenomic medicine and social habits: A regularly taken glass of wine may improve cardiometabolic risks in some patients with type 2 diabetes

Last Updated on

October 28, 2015 – According to a  small prospective and randomized clinical study, just published online in the Annals of Internal Medicine, a regularly taken glass of wine with dinner may improve lipid and glycemic control profiles in patients with type 2 diabetes mellitus.

Findings from the Cardiovascular Diabetes and Ethanol study (CASCADE), which included 224 patients from two centers in Israel with controlled diabetes, showed that those who consumed 150 mL/day of red wine plus a Mediterranean diet had significantly higher levels of HDL cholesterol and apolipoprotein a1 after 2 years compared with those who drank equal amounts of mineral water plus the healthy diet (the primary outcomes). In addition, the group randomized to white wine intake had significantly decreased fasting plasma glucose levels vs the mineral-water group. Both wine groups also had significantly improved triglyceride levels. Of course,  long-term, large-scale multicenter trials would now be needed to follow morbidity and mortality incidence rates in this patient group, in order to still confirm a hightened overall benefit of moderatel alcohol consupmtions  over risks associated. For now, however, the results suggest modest beneficial effects of initiating moderate wine consumption, and, perhaps,  red wine in particular, for this patient group.

All participants underwent several tests, including continuous monitoring of changes in blood pressure (BP), heart rate, and blood glucose levels, and follow-up for the dynamic of atherosclerosis and fat by ultrasound and MRI tests. Most importantly however, genetic analysis of alcohol Ein Glas Wein ADH IIdehydrogenase [ADH] was performed on all study participants, because ADH is know to be polymorphic in the population. This is  particularly important since ADH catalizes the first step in the metabolism of alcohol (i.e., ethanol) to acetaldehyde, which is then further metabolized to acetic acid by aldehyde dehydrogenase (ALDH). In humans, there exist several form of ADH, among them ADH1A, ADH1B, ADH1C, ADH4, and ADH5, to mention a few. Genetic variation in the ADH1B gene leads to a subgroup of individuals (carriers of the ADH1B*1 allelic variant, the so-called slow alcohol metabolizers) who metabolize alcohol muach more slowly than the group of individuals who are carriers of the ADH1B*2 allelic variant (so-called extensive alcohol metabolizers).

In the present study, at the end of 2 years, the red-wine group significantly increased their HDL-C levels by 0.05 mmol/L (2.0 mg/dL) (P<0.001) vs the water group and increased their apolipoprotein a1 level by 0.03 g/L (P=0.05). The red-wine group also decreased total cholesterol/HDL-C ratio by 0.27 (P=0.04). While there were no significant differences in lipid changes between the white-wine and water groups, the white-wine group did significantly decrease their fasting plasma glucose level by 1.0 mmol/L vs the water group (P=0.004)—a result that was not found in the red-wine group. Very interestingly, the carriers of the ADH1B*1 allelic variant  (slow alcohol metabolizers) in the combined wine groups had significant improvements in glycemic control when compared to those who carried ADH1B*2 allelic variant (fast alcohol metabolizers). This also included lower fasting plasma glucose (P=0.01) and HbA1c levels (P=0.02).

This genetic interaction may suggest that ethanol plays an important and perhaps beneficiary role in some type 2 diabetes patiens, when they belong to the poor alcohol metabolizer subgroup, i.e. are carriers of the ADH1B*1 allelic variant of ADH. However, much bigger clinical studies will be necessary to confirm or disprove such beneficiary effects in the long term and measuring hard clinical endpoint for the disease such as mortality and others.

Tags: , , , , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


No comments yet

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • When macrophages are deprived of oxygen May 24, 2019
    Infected tissue has a low concentration of oxygen. The body's standard immune mechanisms, which rely on oxygen, can then only function to a limited extent. How does the immune system nevertheless manage to control bacteria under such conditions? Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Regensburg discovered that fewer metabolites are produced in the citric […]
  • Science Snapshots -- May 2019 May 24, 2019
    Researchers at Berkeley Lab's Molecular Foundry have predicted fascinating new properties of lithium; a powerful combination of experiment and theory has revealed atomic-level details about how silver helps transform carbon dioxide gas into a reusable form; new study reports the first comprehensive, highly coordinated effort to examine the global diversity and biogeography of activated sludge […]
  • Information and language in news impact prejudice against minorities May 23, 2019
    Researchers at the Institute of Psychology show how news about immigrants and language describing immigrants shape prejudice against immigrants and other social minorities, as part of the project 'Immigrants in the Media.' For instance, nouns used for describing the ethnicity of immigrants enhance prejudice against immigrants more than adjectives.
  • Artificial atomic scale materials: Discovering how electrons fatten! May 23, 2019
    A single and isolated electron has a clear electrical charge, magnetic moment and mass, and its free movement can be precisely predicted. Spanish scientists fabricated a nanoscale artificial material manipulating atoms one after the other and discovered that electrons around are very heavier. Heavy electrons are promising particles which endow of new functionalities to novel […]
  • Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear May 23, 2019
    Meaningful studies are lacking for certain patient groups. Disease-specific registries could help close the data gap.